Tevogen Inc. — Form SCHEDULE 13D/A
Filed September 16, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 28/100
What the filing says
This is an amended Schedule 13D filing (13D/A) by Saadi Ryan H., filed on September 16, 2026. The document amends a prior beneficial ownership disclosure but the specific amendments—share count, percentage ownership changes, transaction details, and dollar amounts—are not visible in the header metadata provided. To assess materiality, the actual amended disclosures in the full filing text would be required.
Why this rating
Schedule 13D/A amendments are routine regulatory updates. Without concrete details on ownership % change or share count, cannot assess material impact. Treat as administrative unless filing body shows major shift.
See more from September 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.